Kaizen Financial Strategies’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-607	Closed	-$302K	–	156
2025 Q1	$302K	Buy	607 +4	+0.7%	+$2.17K	0.17%	102
2024 Q4	$314K	Sell	603 -205	-25%	-$113K	0.18%	98
2024 Q3	$500K	Buy	808 +2	+0.2%	+$1.18K	0.29%	57
2024 Q2	$496K	Sell	806 -64	-7%	-$36.7K	0.31%	52
2024 Q1	$506K	Hold	870	–	–	0.34%	53
2023 Q4	$462K	Sell	870 -199	-19%	-$96.3K	0.35%	53
2023 Q3	$541K	Hold	1,069	–	–	0.46%	38
2023 Q2	$562K	Buy	1,069 +3	+0.3%	+$1.62K	0.48%	38
2023 Q1	$615K	Sell	1,066 -202	-16%	-$114K	0.61%	36
2022 Q4	$740K	Buy	1,268 +250	+25%	+$132K	0.73%	37
2022 Q3	$516K	Buy	1,018 +200	+24%	+$112K	0.52%	48
2022 Q2	$444K	Buy	818 +128	+19%	+$70.5K	0.44%	60
2022 Q1	$407K	Buy	690 +39	+6%	+$22.4K	0.32%	73
2021 Q4	$435K	Hold	651	–	–	0.33%	82
2021 Q3	$372K	Buy	+651	New	+$357K	0.3%	86
2021 Q1	$297K	Buy	651 +1	+0.2%	+$477	0.28%	105
2020 Q4	$303K	Buy	+650	New	+$305K	0.34%	90